![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » CRYOCATH ANNOUNCES 2005 FOURTH QUARTER AND FISCAL YEAR END FINANCIAL RESULTS
CRYOCATH ANNOUNCES 2005 FOURTH QUARTER AND FISCAL YEAR END FINANCIAL RESULTS
December 6, 2005
CryoCath Technologies Inc., the global leader in cryotherapy products to treat cardiovascular disease, today announced financial results for the fourth quarter and fiscal year-ended September 30, 2005.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-05-2005/0004227449&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct